Literature DB >> 16219676

In vivo role of the phosphate groove of PDK1 defined by knockin mutation.

Barry J Collins1, Maria Deak, Vicky Murray-Tait, Kate G Storey, Dario R Alessi.   

Abstract

AGC kinases are mediators of signalling responses stimulated by agonists and are activated following phosphorylation at their T-loop residue by the 3-phosphoinositide-dependent protein kinase-1 (PDK1). Agonists stimulate the activation of the AGC kinases p70 ribosomal S6 kinase (S6K), p90 ribosomal S6 kinase (RSK) and serum and glucocorticoid-induced protein kinase (SGK), by inducing the phosphorylation of these enzymes at a non-catalytic regulatory site termed the hydrophobic motif. This creates a high-affinity docking site enabling PDK1 to bind and phosphorylate the T-loop of these enzymes. The site that interacts with these substrates is located on the small lobe of the catalytic domain of PDK1 and is composed of a hydrophobic groove next to a basic phosphate groove. The disruption of the hydrophobic groove ablates activation of S6K, RSK and SGK, but the role of the phosphate groove in regulating the function of PDK1 has not been explored in vivo. We generated knockin ES cells, in which both copies of the gene encoding PDK1 were altered to express a form of PDK1 that retains catalytic activity and integrity of the hydrophobic groove, but in which the phosphate groove was disrupted. The knockin ES cells were viable, mutant PDK1 was expressed at normal levels and IGF1 induced activation of protein kinase B (PKB/Akt), which is a PDK1 substrate that does not require hydrophobic motif phosphorylation to be activated. In the phosphate-groove-knockin ES cells, the activation of S6K, RSK and SGK by agonists, although markedly impaired, was not abolished. PDK1 also phosphorylates the T-loop of protein kinase C (PKC) isoforms, which stabilizes these enzymes. However, in contrast to S6K, RSK and SGK, hydrophobic motif phosphorylation of these enzymes is not thought to control their activation by PDK1. Consistent with this notion, we employed appropriate PDK1-knockin ES cells to demonstrate that the hydrophobic groove of PDK1, but not the phosphate groove, is required for the stabilization of PKC isoforms. These findings provide genetic evidence that the phosphate groove of PDK1 is required for maximal activation of isoforms of S6K, SGK and RSK, but not PKC. We also found that no live births of homozygous phosphate-groove-knockin mice are observed, indicating a key role for this regulatory motif in normal development. The knockin embryos develop to a greater extent than PDK1-knockout and hydrophobic-groove-knockin embryos, which died between E9.5-E11.5. The knockin embryos are observed until E19.5 and displayed general growth retardation and craniofacial developmental defects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16219676     DOI: 10.1242/jcs.02617

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  24 in total

1.  PDK1 regulates vascular remodeling and promotes epithelial-mesenchymal transition in cardiac development.

Authors:  Qiuting Feng; Ruomin Di; Fang Tao; Zai Chang; Shuangshuang Lu; Wenjing Fan; Congjia Shan; Xinli Li; Zhongzhou Yang
Journal:  Mol Cell Biol       Date:  2010-05-10       Impact factor: 4.272

2.  Allosteric activation of the protein kinase PDK1 with low molecular weight compounds.

Authors:  Matthias Engel; Valerie Hindie; Laura A Lopez-Garcia; Adriana Stroba; Francis Schaeffer; Iris Adrian; Jochen Imig; Leila Idrissova; Wolfgang Nastainczyk; Stefan Zeuzem; Pedro M Alzari; Rolf W Hartmann; Albrecht Piiper; Ricardo M Biondi
Journal:  EMBO J       Date:  2006-11-16       Impact factor: 11.598

3.  TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity.

Authors:  Qian Yang; Ken Inoki; Eunjung Kim; Kun-Liang Guan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-20       Impact factor: 11.205

4.  Structure and allosteric effects of low-molecular-weight activators on the protein kinase PDK1.

Authors:  Valerie Hindie; Adriana Stroba; Hua Zhang; Laura A Lopez-Garcia; Leila Idrissova; Stefan Zeuzem; Daniel Hirschberg; Francis Schaeffer; Thomas J D Jørgensen; Matthias Engel; Pedro M Alzari; Ricardo M Biondi
Journal:  Nat Chem Biol       Date:  2009-08-30       Impact factor: 15.040

5.  3-D structure and dynamics of protein kinase B-new mechanism for the allosteric regulation of an AGC kinase.

Authors:  Véronique Calleja; Michel Laguerre; Banafshé Larijani
Journal:  J Chem Biol       Date:  2009-02-20

6.  Genetic and pharmacological inhibition of PDK1 in cancer cells: characterization of a selective allosteric kinase inhibitor.

Authors:  Kumiko Nagashima; Stuart D Shumway; Sriram Sathyanarayanan; Albert H Chen; Brian Dolinski; Youyuan Xu; Heike Keilhack; Thi Nguyen; Maciej Wiznerowicz; Lixia Li; Bart A Lutterbach; An Chi; Cloud Paweletz; Timothy Allison; Youwei Yan; Sanjeev K Munshi; Anke Klippel; Manfred Kraus; Ekaterina V Bobkova; Sujal Deshmukh; Zangwei Xu; Uwe Mueller; Alexander A Szewczak; Bo-Sheng Pan; Victoria Richon; Roy Pollock; Peter Blume-Jensen; Alan Northrup; Jannik N Andersen
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

Review 7.  New insights into the regulation and function of serine/threonine kinases in T lymphocytes.

Authors:  Sharon A Matthews; Doreen A Cantrell
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

8.  Mutation of the PDK1 PH domain inhibits protein kinase B/Akt, leading to small size and insulin resistance.

Authors:  Jose R Bayascas; Stephan Wullschleger; Kei Sakamoto; Juan M García-Martínez; Carol Clacher; David Komander; Daan M F van Aalten; Krishna M Boini; Florian Lang; Christopher Lipina; Lisa Logie; Calum Sutherland; John A Chudek; Janna A van Diepen; Peter J Voshol; John M Lucocq; Dario R Alessi
Journal:  Mol Cell Biol       Date:  2008-03-17       Impact factor: 4.272

9.  Requirement of 3-phosphoinositide-dependent protein kinase-1 for BDNF-mediated neuronal survival.

Authors:  Giorgi Kharebava; Denys Makonchuk; Katarzyna B Kalita; Jing-Juan Zheng; Michal Hetman
Journal:  J Neurosci       Date:  2008-10-29       Impact factor: 6.167

10.  Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR).

Authors:  Juan M García-Martínez; Jennifer Moran; Rosemary G Clarke; Alex Gray; Sabina C Cosulich; Christine M Chresta; Dario R Alessi
Journal:  Biochem J       Date:  2009-06-12       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.